PT Multi Medika Internasional Tbk

IDX:MMIX Stock Report

Market Cap: Rp304.8b

Multi Medika Internasional Management

Management criteria checks 2/4

Multi Medika Internasional's CEO is Mengky Mangarek, appointed in Jan 2022, has a tenure of 3.08 years. directly owns 6% of the company’s shares, worth IDR18.29B. The average tenure of the management team and the board of directors is 3.1 years and 3.1 years respectively.

Key information

Mengky Mangarek

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.1yrs
CEO ownership6.0%
Management average tenure3.1yrs
Board average tenure3.1yrs

Recent management updates

Recent updates


CEO

Mengky Mangarek (52 yo)

3.1yrs

Tenure

Mr. Mengky Mangarek, S.E., MBA, is Founder & Director of PT Multi Medika Internasional Tbk and serves as its President Director since January 2022. He Graduated in SE – ACCOUNTING from Universitas Tarumane...


Leadership Team

NamePositionTenureCompensationOwnership
Mengky Mangarek
President Director3.1yrsno data6%
IDR 18.3b
Eveline Susanto
Co-Founder3.1yrsno data6%
IDR 18.3b
Christopher Lee
COO & Director3.1yrsno data0.10%
IDR 304.0m

3.1yrs

Average Tenure

Experienced Management: MMIX's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mengky Mangarek
President Director3.1yrsno data6%
IDR 18.3b
Eveline Susanto
Co-Founderno datano data6%
IDR 18.3b
Christopher Lee
COO & Directorno datano data0.10%
IDR 304.0m
Togu Simanjuntak
Independent Commissioner2.4yrsno datano data
Allen Feliciano
Commissioner4.4yrsno data1.5%
IDR 4.6b
Hillary Josephine
President Commissioner3.1yrsno data1.5%
IDR 4.6b

3.1yrs

Average Tenure

52yo

Average Age

Experienced Board: MMIX's board of directors are considered experienced (3.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 23:22
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Multi Medika Internasional Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.